New Report Analyses Opportunities in the Iron Drug Market

Top Quote Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report presenting statistics on the growing population of patients who are suffering from critical conditions that calls for the need of iron drugs. End Quote
  • (1888PressRelease) February 18, 2009 - The report “Global Intravenous (IV) Iron Drugs Market: Potential Opportunities”, available at reports that iron deficiency anemia or IDA is among one of the top ten most important public health issues, according to the World Health Organization.

    The report shows that with approximately one-third of the current global population facing the problem of iron deficiency, more and more people are likely to suffer from a lack of iron in their diet in the near future due to changes in eating habits and rising life expectancy.

    Currently, iron supplements used in the context of IDA account for the majority share of the iron-based medicines but this is likely to change with the growing utility of intravenous iron (IV) drugs.
    Earlier, the IV iron market was mainly achieved in the hemodialysis (HD) setting, but IV iron is likely to be used more in many other therapeutic areas which are highly under-penetrated.

    Authors of the 32 page report note that one of the major attractiveness of IV iron especially in regions outside the United States is its pricing and growing number of CKD population. Generally the pricing of IV irons outside the U.S. is lower and the iron market in countries like China is underdeveloped, but growing rapidly, with tremendous potential.

    Venofer from Galenica Limited has emerged as the undisputed leader in the IV iron drugs market overtaking the market share of Watson's InFed and Ferrlecit. Still the whole IV iron market holds immense business opportunities mainly because of increase in the number of haemodialysis patients and limitation in various iron replacement therapies and scope for innovation.

    The report “Global Intravenous (IV) Iron Drugs Market: Potential Opportunities” is available from Report Buyer at:

    Report Buyer product ID: KOA04342

    About Report Buyer.
    Report Buyer ( is a UK-based independent online store supplying business information. The website now carries over 90,000 business information products, including market reports, studies, books and events. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest.

  • FB Icon Twitter Icon In-Icon
Contact Information